Form 8-K - Current report:
SEC Accession No. 0001213900-25-003861
Filing Date
2025-01-15
Accepted
2025-01-15 16:32:23
Documents
13
Period of Report
2025-01-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022783801-8k_enzobio.htm   iXBRL 8-K 20203
  Complete submission text file 0001213900-25-003861.txt   191012

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20250113.xsd EX-101.SCH 3021
3 XBRL LABEL FILE enz-20250113_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enz-20250113_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT ea022783801-8k_enzobio_htm.xml XML 3557
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 25533295
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)